This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lanoue, E. Articles by Day, R. Search for Related Content PubMed PubMed Citation Articles by Lanoue, E. Articles by Day, R.

Coexpression of Proprotein Convertase SPC3 and the Neuroendocrine Precursor ProSAAS¹

Department of Pharmacology, Faculté de Médecine and Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada, J1H 5N4

Address all correspondence and requests for reprints to: Robert Day, Ph.D., Département de Pharmacologie, Faculté de Médecine, Institut de Pharmacologie, Université de Sherbrooke, 3001 12^e Avenue Nord, Sherbrooke, Québec, Canada, J1H 5N4. E-mail: rday{at}courrier.usherb.ca

The subtilisin-like proprotein convertases are a family of serine proteinases involved in the processing of secreted proteins via cleavage at paired basic residues. Until recently, only one natural inhibitor had been demonstrated, the neuropeptide 7B2, which contains a C-terminal domain with inhibitory activity against SPC2. A novel granin-like peptide precursor, named proSAAS, has recently been identified that contains potent and specific inhibitory activity on SPC3 in vitro. To exert such an inhibitory action of SPC3 activity, it would be important to demonstrate that proSAAS and SPC3 are colocalized. We have studied the expression of proSAAS and SPC3 mRNAs in the rat central nervous system and various peripheral tissues by in situ hybridization histochemistry. Our results show that, like 7B2, proSAAS is expressed with a panneuronal distribution. In the periphery, proSAAS is an excellent marker of endocrine cells. Double labeling studies show that SPC3 expression is nearly always accompanied by proSAAS expression. However, proSAAS was also found to be expressed in endocrine cells and neurons that did not express SPC3, suggesting that proSAAS could have additional functions other than the modulation of SPC3 activity. These data support the hypothesis that one of the roles of proSAAS may be to modulate the activity of SPC3.

This article has been cited by other articles:

				H. Kudo, J. Liu, E. J. R. Jansen, A. Ozawa, P. Panula, G. J. M. Martens, and I. Lindberg Identification of proSAAS Homologs in Lower Vertebrates: Conservation of Hydrophobic Helices and Convertase-Inhibiting Sequences Endocrinology, March 1, 2009; 150(3): 1393 - 1399. [Abstract] [Full Text] [PDF]

				N. A. TAYLOR, W. J. M. VAN DE VEN, and J. W. M. CREEMERS Curbing activation: proprotein convertases in homeostasis and pathology FASEB J, July 1, 2003; 17(10): 1215 - 1227. [Abstract] [Full Text] [PDF]